Emerald Advisers Inc. PA boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 24,423 shares of the medical instruments supplier’s stock after buying an additional 3,524 shares during the period. Emerald Advisers Inc. PA’s holdings in DENTSPLY SIRONA were worth $1,584,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Howard Hughes Medical Institute increased its stake in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 1,580 shares during the last quarter. Penserra Capital Management LLC increased its stake in DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the last quarter. Howland Capital Management LLC bought a new stake in DENTSPLY SIRONA during the first quarter worth $203,000. IBM Retirement Fund increased its stake in DENTSPLY SIRONA by 29.9% in the second quarter. IBM Retirement Fund now owns 3,324 shares of the medical instruments supplier’s stock worth $216,000 after buying an additional 766 shares during the last quarter. Finally, Gilbert & Cook Inc. bought a new stake in DENTSPLY SIRONA during the second quarter worth $225,000. Hedge funds and other institutional investors own 95.13% of the company’s stock.
DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 53.17 on Friday. The company’s market cap is $12.20 billion. DENTSPLY SIRONA Inc. has a 12-month low of $52.73 and a 12-month high of $65.68. The firm’s 50-day moving average is $61.68 and its 200 day moving average is $62.21.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.65. The firm had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.76 earnings per share. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.72 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/08/18/emerald-advisers-inc-pa-has-1-58-million-stake-in-dentsply-sirona-inc-nasdaqxray-updated-updated.html.
A number of research analysts recently issued reports on the stock. BidaskClub lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective for the company in a report on Thursday, July 13th. Credit Suisse Group reiterated an “outperform” rating and issued a $75.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. HC Wainwright assumed coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price objective for the company. Finally, Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $66.25.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
